BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 27
• 28

• Drug Development

  Cancer Vaccine Specialist Scancell’s SCIB1 Phase 1/2 Clinical Trial Reports Preliminary Evidence of Immune Response and Clinical Benefit

  December 6, 2012

   · 

  1 min read
• Genetown

  ArQule, Inc. to Present at Oppenheimer Healthcare Conference

  December 6, 2012

   · 

  1 min read
• Business

  BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2012

  December 6, 2012

   · 

  1 min read
• Curetis Initiates Clinical Trial in the U.S. Towards FDA Clearance

  December 6, 2012

   · 

  4 min read
• Pharm Country

  Derma Sciences, Inc. Announces Pricing of Underwritten Public Offering of Common Stock

  December 6, 2012

   · 

  1 min read
• Drug Development

  VG Life Sciences, Inc. Provides Additional Insight Into Clinical Trial

  December 6, 2012

   · 

  1 min read
• Genetown

  ImmunoGen, Inc. Announces Webcast of Presentation at the Oppenheimer 23rd Annual Healthcare Conference

  December 6, 2012

   · 

  1 min read
• Business

  Jones Lang LaSalle Completes Development of Max Planck Florida Institute for Neuroscience World-Renowned Scientific Research Organization has Moved Into Its First Location Outside of Europe, a 100,000-Square-Foot Class a Research Center at Florida Atlanti

  December 6, 2012

   · 

  5 min read
• BioMidwest

  Impact Analytical Expansion Offers Immediate Results and Long-Term Potential

  December 6, 2012

   · 

  2 min read
• ISPE Announces 2012 Award Winners at Global Annual Meeting

  December 6, 2012

   · 

  3 min read